Chronic obstructive pulmonary disease (COPD) remains a substantial contributor to morbidity and mortality in the United States with an estimated 3.8% age-adjusted prevalence and 141,733 COPD deaths ...

Recalibrating the ACCEPT COPD exacerbation prediction tool with country-specific background risk substantially improved its ...

A narrative review synthesizes real-world evidence supporting single-inhaler triple therapy and the emergence of dupilumab, ...

GINA 2026 no longer endorses a SABA alone for asthma, yet albuterol labels still list only bronchospasm. Airsupra adds exacerbation risk reduction for adults.

We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. November 20 marks World COPD Day 2024, a worldwide ...

The natriuretic peptides, specifically brain natriuretic peptide (BNP), are the most specific and applicable laboratory tests available to establish fluid overload associated with HF. 9 BNP is ...